# Mebeverine

## Dobecon 100mg

| 藥物代碼           | ODOB                                                                                                                                                                                                                                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Diarrhea, abdominal pain & flatulence due to irritable colon, diverticulitis                                                                                                                                                                                                                        |
| 副作用             | Skin rash, hives, dizziness, headache                                                                                                                                                                                                                                                               |
| 禁忌               | 1. Hypersensitivity to mebeverine 2.Severe hepatic impairment 3.Cystic fibrosis                                                                                                                                                                                                                     |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                |
| 用法用量           | Adult: The usual oral adult dose of mebeverine hydrochloride for irritable bowel syndrome is one 100 mg tablet 3 times daily taken with fluids 20 minutes before a meal. The dosage of mebeverine may be reduced gradually after a few weeks of treatment, if the desired effect has been achieved. |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                        |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                        |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                            |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                 |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                 |
| 哺乳期用藥建議     | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                      |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                 |
| 注射劑給藥建議途徑 | AC, AC15, PO                                                                                                                                                                                                                                                                                        |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                 |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                 |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                 |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                 |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                 |

